{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:28:14Z","timestamp":1761128894006},"reference-count":18,"publisher":"EDP Sciences","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1051\/medsci\/200319111146","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T17:09:10Z","timestamp":1299344950000},"page":"1146-1151","source":"Crossref","is-referenced-by-count":4,"title":["Quels sont les probl\u00e8mes pos\u00e9s par la tuberculose en France en 2003\u00a0?"],"prefix":"10.1051","volume":"19","author":[{"given":"Elisabeth","family":"Bouvet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"250","published-online":{"date-parts":[[2003,11,15]]},"reference":[{"key":"R1","unstructured":"Schwoebel V, Hubert B, Desenclos JC. Investigations \u00e0 conduire autour d\u2019un cas de tuberculose ou de primo-infection tuberculeuse r\u00e9cente.BEH1994; 9: 39\u201342."},{"key":"R2","unstructured":"Styblo K. Recent advances in epidemiological research in tuberculosis.Adv Tuberc Res1980; 20: 1\u201363."},{"key":"R3","doi-asserted-by":"crossref","unstructured":"Van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements.J Intern Med2001; 249: 1\u201326.","DOI":"10.1046\/j.1365-2796.2001.00772.x"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"Geng E, Kreiswirth B, Driver C,et al.Changes in the transmission of tuberculosis in New York City from 1990 to 1999.N Engl J Med2002; 346: 1453\u20138.","DOI":"10.1056\/NEJMoa012972"},{"key":"R5","unstructured":"INVS (Institut de veille sanitaire).Impact \u00e9pid\u00e9miologique d\u2019une modification de la politique de vaccination par le BCG en France. Revue de la litt\u00e9rature et analyse des donn\u00e9es disponibles. Saint-Maurice: INVS, 2001."},{"key":"R6","doi-asserted-by":"crossref","unstructured":"Behr MA, Warren SA, Salamon H,et al.Transmission ofMycobactrium tuberculosisfrom patients smearnegative for acid-fast bacilli.Lancet1999; 353: 444\u20139.","DOI":"10.1016\/S0140-6736(98)03406-0"},{"key":"R7","unstructured":"Decludt B, Campese C. Les cas de tuberculose d\u00e9clar\u00e9s en France en 2000.BEH2002; 16-17: 68\u201370."},{"key":"R8","unstructured":"Infuso A, Antoine D, Barboza P, Euro TB. Surveillance europ\u00e9enne de la tuberculose en 1999 et tendances r\u00e9centes.BEH2002; 16-17: 66\u20137."},{"key":"R9","unstructured":"WHO (World health organization).Antituberculosis drug resistance in the world. Report n\u00b02. Prevalence and trends. Gen\u00e8ve: WHO, 2000."},{"key":"R10","unstructured":"CDC (Centers for disease control and prevention). Epidemiologic notes and reports. Nosocomial transmission of multidrugresistant tuberculosis among HIV-infected persons, Florida and New York, 1988-1991.MMWR Morb Mortal Wkly Rep1991; 40: 585\u201391."},{"key":"R11","unstructured":"Robert J, Trystram D, Truffot-Pernot C, Jarlier V. Surveillance de la tuberculose \u00e0 bacilles multir\u00e9sistants en France en 1998.BEH2002; 16-17: 73\u20136."},{"key":"R12","doi-asserted-by":"crossref","unstructured":"Schluger NW, Rom WN. The host immune response to tuberculosis.Am J Respir Crit Care Med1998; 157: 679\u201391.","DOI":"10.1164\/ajrccm.157.3.9708002"},{"key":"R13","doi-asserted-by":"crossref","unstructured":"Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project.JAMA1999; 282: 677\u201386.","DOI":"10.1001\/jama.282.7.677"},{"key":"R14","doi-asserted-by":"crossref","unstructured":"Badri M, Wilson D,Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.Lancet2002; 359: 2059\u201364.","DOI":"10.1016\/S0140-6736(02)08904-3"},{"key":"R15","unstructured":"INVS (Institut de veille sanitaire). Surveillance du SIDA en France. Situation au 31 mars 2002.BEH2002; 27: 133\u20138."},{"key":"R16","unstructured":"CDC (Centers for disease control and prevention). Targeted tuberculin testing and treatment of latent tuberculosis infection.MMWR Recomm Rep2000; 49: RR\u20136."},{"key":"R17","doi-asserted-by":"crossref","unstructured":"Gordin FM, Chaisson RE, Matts JP,et al.An international randomized trial of rifampin and pyrazinamideversusisoniazid for prevention of tuberculosis in HIVinfected persons.JAMA2000; 283: 1445\u201350.","DOI":"10.1001\/jama.283.11.1445"},{"key":"R18","doi-asserted-by":"crossref","unstructured":"Bailey WC, Gerald LB, Kimerling ME,et al.Predictive model to identify positive tuberculosis skin test results during contact investigations.JAMA2002; 287: 996\u20131002.","DOI":"10.1001\/jama.287.8.996"}],"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200319111146\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T21:58:29Z","timestamp":1560031109000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.medecinesciences.org\/10.1051\/medsci\/200319111146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":18,"journal-issue":{"issue":"11"},"alternative-id":["medsci20031911p1146"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/200319111146","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}